119th Congress
H.R. 9635
Getting Innovations to Patients During Shutdowns Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Kevin Mullin(D-CA)
- Introduced
- Jul 9, 2026
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (0)
No cosponsors.
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.
Latest action(Jul 9, 2026): Referred to the House Committee on Energy and Commerce.
Roll-call votes
No recorded votes on this bill.
Actions
- Jul 9, 2026 · House
Referred to the House Committee on Energy and Commerce. - Jul 9, 2026
Introduced in House